In vivo base editing restores sensory transduction and transiently improves auditory function in a mouse model of recessive deafness.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
03 06 2020
Historique:
received: 28 07 2019
accepted: 05 04 2020
entrez: 5 6 2020
pubmed: 5 6 2020
medline: 24 6 2021
Statut: ppublish

Résumé

Most genetic diseases arise from recessive point mutations that require correction, rather than disruption, of the pathogenic allele to benefit patients. Base editing has the potential to directly repair point mutations and provide therapeutic restoration of gene function. Mutations of transmembrane channel-like 1 gene (

Identifiants

pubmed: 32493795
pii: 12/546/eaay9101
doi: 10.1126/scitranslmed.aay9101
pmc: PMC8167884
mid: NIHMS1701929
pii:
doi:

Substances chimiques

Membrane Proteins 0
TMC1 protein, mouse 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHGRI NIH HHS
ID : RM1 HG009490
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM118062
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC013521
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI142756
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD090255
Pays : United States
Organisme : NCATS NIH HHS
ID : UG3 TR002636
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

Cell Rep. 2015 Sep 8;12(10):1606-17
pubmed: 26321635
Nat Biotechnol. 2017 Mar;35(3):280-284
pubmed: 28165475
Nat Neurosci. 2003 Oct;6(10):1019-20
pubmed: 12973354
Sci Transl Med. 2015 Jul 8;7(295):295ra108
pubmed: 26157030
Nat Med. 2013 Mar;19(3):345-50
pubmed: 23380860
Nat Genet. 2002 Mar;30(3):277-84
pubmed: 11850618
Nature. 2016 Jan 28;529(7587):490-5
pubmed: 26735016
Int J Oncol. 2018 Aug;53(2):443-468
pubmed: 29901119
Int J Pediatr Otorhinolaryngol. 2009 May;73(5):699-705
pubmed: 19187973
J Clin Invest. 2011 Dec;121(12):4796-809
pubmed: 22105175
Neuron. 2018 Aug 22;99(4):736-753.e6
pubmed: 30138589
Sci Adv. 2017 Aug 30;3(8):eaao4774
pubmed: 28875174
Nucleic Acids Res. 1994 Dec 25;22(25):5649-57
pubmed: 7838718
Trends Biochem Sci. 2016 Jul;41(7):578-594
pubmed: 27283515
Annu Rev Med. 2019 Jan 27;70:273-288
pubmed: 30477394
Cold Spring Harb Perspect Med. 2015 Jan 29;5(9):a017285
pubmed: 25635059
Am J Pathol. 2012 Apr;180(4):1560-9
pubmed: 22330676
Clin Genet. 2007 Feb;71(2):148-52
pubmed: 17250663
J Neurosci. 2003 May 15;23(10):4054-65
pubmed: 12764092
J Biol Chem. 2009 Aug 21;284(34):22898-904
pubmed: 19561087
Nucleic Acids Res. 2016 Jan 4;44(D1):D862-8
pubmed: 26582918
Nat Biotechnol. 2018 Oct;36(9):843-846
pubmed: 29813047
Science. 2018 Sep 21;361(6408):1259-1262
pubmed: 30166441
Nat Struct Mol Biol. 2011 Feb;18(2):230-6
pubmed: 21258325
Mol Cell Biol. 2017 Sep 26;37(20):
pubmed: 28716949
Nature. 2019 May;569(7756):433-437
pubmed: 30995674
Mol Ther. 2017 Mar 1;25(3):780-791
pubmed: 28254438
Nat Rev Dis Primers. 2017 Jan 12;3:16094
pubmed: 28079113
Biochemistry. 2019 Sep 10;58(36):3727-3734
pubmed: 31433621
Nat Methods. 2017 Jun;14(6):607-614
pubmed: 28459458
J Clin Invest. 2013 Sep;123(9):4036-49
pubmed: 23979167
Nature. 2018 Apr 5;556(7699):57-63
pubmed: 29512652
Sci Adv. 2019 May 08;5(5):eaax5717
pubmed: 31086823
Mol Cell Biol. 1994 Dec;14(12):8096-106
pubmed: 7969147
J Physiol. 2006 Aug 1;574(Pt 3):677-98
pubmed: 16627570
Nature. 2017 Nov 23;551(7681):464-471
pubmed: 29160308
Nat Biotechnol. 2017 Mar;35(3):264-272
pubmed: 28165476
Neuron. 2012 Jul 26;75(2):283-93
pubmed: 22841313
Nat Commun. 2019 Jan 25;10(1):427
pubmed: 30683875
Nat Biotechnol. 2019 Sep;37(9):1070-1079
pubmed: 31332326
Nucleic Acids Res. 2015 Jul 27;43(13):6450-8
pubmed: 26082496
Curr Mol Med. 2009 Jun;9(5):546-64
pubmed: 19601806
J Assoc Res Otolaryngol. 2017 Oct;18(5):649-670
pubmed: 28815315
Sci Rep. 2017 Apr 03;7:45524
pubmed: 28367981
Neurogenetics. 2016 Apr;17(2):115-123
pubmed: 26879195
Mol Ther. 2011 Jan;19(1):16-27
pubmed: 21119617
Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14225-30
pubmed: 23942124
Nature. 2016 Apr 20;533(7603):420-4
pubmed: 27096365
Science. 2016 Sep 16;353(6305):
pubmed: 27492474
Nat Rev Genet. 2018 Dec;19(12):770-788
pubmed: 30323312
Nat Biomed Eng. 2020 Jan;4(1):97-110
pubmed: 31937940
Nat Med. 2018 Oct;24(10):1519-1525
pubmed: 30297904
EMBO Mol Med. 2013 Nov;5(11):1642-61
pubmed: 24106209
Nat Biotechnol. 2017 Apr;35(4):371-376
pubmed: 28191901
Nat Commun. 2019 Jan 22;10(1):236
pubmed: 30670701
Science. 2019 Apr 19;364(6437):292-295
pubmed: 30819931
Nature. 2019 Jul;571(7764):275-278
pubmed: 31181567
Nat Med. 2019 Jul;25(7):1123-1130
pubmed: 31270503
Nat Biotechnol. 2017 May;35(5):475-480
pubmed: 28398345
Nucleic Acids Res. 2014 Jan;42(Database issue):D980-5
pubmed: 24234437
Adv Genet. 1998;38:185-218
pubmed: 9677708
J Assoc Res Otolaryngol. 2018 Feb;19(1):1-16
pubmed: 29027038
J Virol. 2000 Feb;74(3):1524-32
pubmed: 10627564
Mol Cell Biol. 2007 Dec;27(23):8038-48
pubmed: 17893327
Nature. 2018 Jan 11;553(7687):217-221
pubmed: 29258297
J Neurosci. 2015 Nov 25;35(47):15582-98
pubmed: 26609154
Mol Genet Genomic Med. 2018 Apr 14;:
pubmed: 29654653
Genomics Inform. 2018 Dec;16(4):e20
pubmed: 30602081

Auteurs

Wei-Hsi Yeh (WH)

Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Program in Speech and Hearing Bioscience and Technology, Harvard Medical School, Boston, MA 02115, USA.

Olga Shubina-Oleinik (O)

Department of Otolaryngology, F.M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.

Jonathan M Levy (JM)

Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.

Bifeng Pan (B)

Department of Otolaryngology, F.M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.

Gregory A Newby (GA)

Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.

Michael Wornow (M)

Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.

Rachel Burt (R)

Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, VIC 3052, Australia.

Jonathan C Chen (JC)

Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.

Jeffrey R Holt (JR)

Department of Otolaryngology, F.M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA. jeffrey.holt@childrens.harvard.edu drliu@fas.harvard.edu.
Department of Neurology, F.M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.

David R Liu (DR)

Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. jeffrey.holt@childrens.harvard.edu drliu@fas.harvard.edu.
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Howard Hughes Medical Institute, Harvard University, Cambridge, MA 02138, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH